MedicarePartD.guide

A non-government resource built from CMS public data

HIV treatment and prevention on every 2026 Michigan Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Michigan cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

HIV treatment and prevention by 2026 Michigan Part D plan
DrugWellcare Classic$0.00/moS4802-084Wellcare Value Script$0.00/moS4802-148HealthSpring Assurance Rx$0.00/moS5617-221Humana Basic Rx Plan$0.00/moS5884-136Humana Value Rx Plan$0.00/moS5884-192AARP Medicare Rx Saver from UHC$14.10/moS5921-358HealthSpring Extra Rx$50.40/moS5617-363SilverScript Choice$78.30/moS5601-026AARP Medicare Rx Preferred from UHC$78.30/moS5921-394Prescription Blue Select$78.40/moS5584-001Humana Premier Rx Plan$98.10/moS5884-159Prescription Blue Premium$106.70/moS5584-002
Biktarvybictegravir/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%Tier 531%QL 30/30dTier 525%QL 31/31dTier 533%QL 30/30dTier 533%QL 31/31d
Dovatodolutegravir and lamivudineTier 525%Tier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%Tier 531%QL 30/30dTier 525%Tier 533%QL 30/30dTier 533%
Triumeqabacavir/dolutegravir/lamivudineTier 428%Tier 440%Tier 430%QL 300/30dTier 433%QL 180/30dTier 433%QL 180/30dTier 433%QL 180/30dTier 432%QL 300/30dTier 433%Tier 432%QL 180/30dTier 425%QL 180/30dTier 450%QL 180/30dTier 427%QL 180/30d
Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%QL 31/31dTier 533%QL 30/30dTier 533%QL 31/31d
Odefseyemtricitabine/rilpivirine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%Tier 533%QL 30/30dTier 533%
Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%Tier 531%QL 30/30dTier 525%Tier 533%QL 30/30dTier 533%
Julucadolutegravir and rilpivirineTier 525%Tier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%Tier 531%QL 30/30dTier 525%QL 31/31dTier 533%QL 30/30dTier 533%QL 31/31d
Descovyemtricitabine and tenofovir alafenamideTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 525%Tier 531%QL 30/30dTier 525%QL 31/31dTier 533%QL 30/30dTier 533%QL 31/31d
Truvadaemtricitabine and tenofovir disoproxilNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
emtricitabine-tenofovirgeneric TruvadaTier 428%QL 30/30dTier 440%QL 30/30dTier 430%QL 30/30dTier 433%QL 30/30dTier 433%QL 30/30dTier 433%QL 30/30dTier 432%QL 30/30dTier 433%QL 30/30dTier 432%QL 30/30dTier 320%QL 31/31dTier 450%QL 30/30dTier 324%QL 31/31d
TivicaydolutegravirTier 525%Tier 525%Tier 430%QL 180/30dTier 525%QL 60/30dTier 526%QL 60/30dTier 525%QL 60/30dTier 432%QL 180/30dTier 525%Tier 531%QL 60/30dTier 525%QL 62/31dTier 533%QL 60/30dTier 533%QL 62/31d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.